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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 














The Lancet | 
Article 
 This article is 













 Only approx. 
5% had C19 
antibodies with 
no differences 
















lower in coastal 
areas (<3%) 
 95% of people 
in Spain are still 
susceptible, 


















04.07.2020 The projected 
impact of mitigation 
and suppression 



















from 1.9 (95% 
CI 1.7-2.2) to 
1.3 (95% CI 




 This study 
estimates that 
continued 
spread is likely 
to peak in 
October, and to 
overwhelm the 
healthcare 



















 Rapid scale up 
of hospital 
capacity is 
likely to be 
needed 





of the COVID-19 
virus 
Cell | Article 
 A SARS-CoV-2 
variant with a 
change in an 





form in the 
global 
pandemic with 















the new variant 













 Important for a 
mechanistic 
understanding 
of the virus, 






























 A detailed comparison of 
serological COVID-19 
assays shows a wide 
diversity in assay 
performance in different 
scenarios and when 
correlated to virus 
neutralising antibodies 
  Serological 
assays 













 Assessment of the 
quantitative impact of 
government 
interventions on 
deaths related to the 
C19 outbreak 
 The greater the 
strength of 
government 
interventions at an 




effective these are in 
slowing down or 
reversing the growth 
rate of deaths 
 Informative for future 
C19 waves and for 
other future 
pandemics  
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
July 2020 COVID-19 testing in Africa: 
lessons learnt 
The Lancet Microbe | 
Comment 
Pascale 
Ondoa et al. 
July 2020 COVID-19: a multifaceted threat 
to refugee camps 
The Lancet Microbe | News Talha Burki 
July 2020 Development of potential COVID-
19 vaccines continues to 
accelerate 
The Lancet Microbe | News Tony Kirby 
06.07.2020 The Indirect Health Effects of 
COVID-19: long-term costs for 
health systems 
CGD | Blog Lydia Regan 
Y-Ling Chi 
06.07.2020 WHO: access to HIV medicines 
severely impacted by COVID-19 
as AIDS response stalls 
WHO | News  
06.07.2020 SARS-CoV-2 seroprevalence in 
COVID-19 hotspots 




03.07.2020 Six months of coronavirus: the 
mysteries scientists are still racing 
to solve 






03.07.2020 Oxygen availability in sub-
Saharan African countries: a call 
for data to inform service delivery 
The Lancet Global 









03.07.2020 Pulse oximetry in low-resource 
settings during the COVID-19 
pandemic 
The Lancet Global Health | 
Correspondence 
Nicola Starr et 
al. 
03.07.2020 Decisive leadership is a necessity 
in the COVID-19 response 
The Lancet | Comment Ahmed 
Mohammed 
Obaid Al Saidi 
et al. 
01.07.2020 How to predict – and prevent – the 
next pandemic 
The Economist | Weekly 
podcast (24 min) 
 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
01.05.2020 COVID-19 
considerations for 
home and community 
care 
SSHAP 
 This review gives an overview of 
existing guidance and models for 
home and community-based care 
for C19, with an emphasis on 
LMICs 
 Gaps in the guidance are assessed 
and ways these may be addressed 
suggested. This includes 
highlighting innovative examples 
and drawing on knowledge of past 
outbreaks 
 Recommendations are aimed at 
governments, NGOs and relevant 
community-based organisations  
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  Sierra 
Leone 





US NIH  Our World 
in Data: C19 
Testing 







Our World in 
Data 






      
Global 5050 









  US  COVID-19 
Primer 





     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 




              
C19 Resource Hubs 









  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 







  IDA 






















g in low 
resource 
settings 















































Institute of Public 
Health 
    





Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The 
Lancet 
 HEART     




 UKRI     
UN WFP   NEJM  Evidence Aid     
GOARN   Oxford 
University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
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Our World in 
Data 




  Springer 
Nature 
      
Reliefweb   SSRN 
(Preprints)  












      
WorldPop           
Flowminder           





    
  
GISAID           
  
11 
Online learning & events 











Online event 1h 30 JLN, WB, USAID, 






treatment of severe 
COVID-19  






mitigating the collateral 
effects of COVID-19 
Online event 1h 30 CGD 
13 July 




Lecture: Global Health 
Preparedness by Dr 
Muhammad Pate, 
Global Director for 
Health, Nutrition and 








UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 







Africa’s leadership role 
in COVID-19 vaccine 
development and 
access 












Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 




WHO Academy and 
WHO Info mobile 
applications 




Modelling and Policy 
Online 
learning 













Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr 
Peter Lachman, Dr 
Teri Rynolds & Dr Ed 
Kelley 




5 hours Johns Hopkins 




Virtual Evidence Weeks 5 sessions 1h 30 International Initiative 











COVID-19 Open online 
brief with Dr David 
Nabarro 
Event 1h 4SD 
13 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 





COVID-19: methods for 
detection, prevention, 
response and control 
Online 
learning 




19: Real-time training 

















































Edinburgh & Royal 
College of Physicians 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
